Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2020-06-26

New medicine for cystic fibrosis patients

View source ↗

Summary

EMA announces a new medicine for cystic fibrosis patients, signaling an important approval or landmark development for CF treatment in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications